Navigation Links
Seeing the world with new eyes: Biosynthetic corneas restore vision in humans
Date:8/25/2010

A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans. The results, from an early phase clinical trial with 10 patients, are published in the August 25th, 2010 issue of Science Translational Medicine.

"This study is important because it is the first to show that an artificially fabricated cornea can integrate with the human eye and stimulate regeneration," said senior author Dr. May Griffith of the Ottawa Hospital Research Institute, the University of Ottawa and Linkping University. "With further research, this approach could help restore sight to millions of people who are waiting for a donated human cornea for transplantation."

The cornea is a thin transparent layer of collagen and cells that acts as a window into the eyeball. It must be completely transparent to allow the light to enter and it also helps with focus. Globally, diseases that lead to clouding of the cornea represent the most common cause of blindness. More than a decade ago, Dr. Griffith and her colleagues began developing biosynthetic corneas in Ottawa, Canada, using collagen produced in the laboratory and moulded into the shape of a cornea. After extensive laboratory testing, Dr. Griffith began collaborating with Dr. Per Fagerholm, an eye surgeon at Linkping University in Sweden, to provide the first-in-human experience with biosynthetic cornea implantation.

Together, they initiated a clinical trial in 10 Swedish patients with advanced keratoconus or central corneal scarring. Each patient underwent surgery on one eye to remove damaged corneal tissue and replace it with the biosynthetic cornea, made from synthetically cross-linked recombinant human collagen. Over two years of follow-up, the researchers observed that cells and nerves from the patients' own corneas had grown into the implant, resulting in a "regenerated" cornea that resembled normal, healthy tissue. Patients did not experience any rejection reaction or require long-term immune suppression, which are serious side effects associated with the use of human donor tissue. The biosynthetic corneas also became sensitive to touch and began producing normal tears to keep the eye oxygenated. Vision improved in six of the ten patients, and after contact lens fitting, vision was comparable to conventional corneal transplantation with human donor tissue.

"We are very encouraged by these results and by the great potential of biosynthetic corneas," said Dr. Fagerholm. "Further biomaterial enhancements and modifications to the surgical technique are ongoing, and new studies are being planned that will extend the use of the biosynthetic cornea to a wider range of sight-threatening conditions requiring transplantation."


'/>"/>

Contact: Jennifer Paterson
jpaterson@ohri.ca
613-798-5555 x73325
Ottawa Hospital Research Institute
Source:Eurekalert  

Related biology technology :

1. Seeing moire in graphene
2. Seeing the quantum in chemistry: JILA scientists control chemical reactions of ultracold molecules
3. bioserie Introduces the Worlds First Made of Plants iPhone 4 Cover
4. Regenicin Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville
5. The nano world of Shrinky Dinks
6. New Test Centre in India: TUV Rheinland Continues Worldwide Investment Programme for Solar Industry
7. New Advances in Understanding of Parasite Risk Showcased at CVBD World Forum
8. Engineering researchers simplify process to make worlds tiniest wires
9. United Nations' World Population Day Calls Attention to Key Global Issues
10. Aeterna Zentaris: Perifosine Data Selected for Oral Presentation at Upcoming 12th World Congress on Gastrointestinal Cancer
11. Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Seeing the world with new eyes: Biosynthetic corneas restore vision in humans
(Date:2/28/2017)... SHANGHAI , CAMBRIDGE, Mass. and ... --  WuXi NextCODE , a WuXi AppTec group ... today announced that the company,s chief operating officer Hannes Smarason ... WuXi AppTec senior vice presidents John Long and ... and chief operating officer, respectively. "WuXi NextCODE ...
(Date:2/28/2017)... 28, 2017 WuXi AppTec, a leading ... and technology platform company, today announced that its ... Shanghai once again passed US FDA,s ... The inspectors from FDA thoroughly audited WuXi,s ... scientific data integrity, operation infrastructure, equipment, sample storage, ...
(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... ... trials, yet requires extensive coordination and expertise. Colpitts Clinical Trial Travel and ... 15 years of meeting this unique need within the biotechnology and pharmaceutical industries ...
(Date:2/28/2017)... PA (PRWEB) , ... February 28, 2017 , ... Over ... them children. In a new educational webinar on March 7, DrugDev will ... professionals working in this especially difficult area. , Webinar: Overcoming the Challenges of ...
Breaking Biology Technology:
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
Breaking Biology News(10 mins):